Hildebrandt Clara C, Patel Nisha, Graham John M, Bamshad Michael, Nickerson Deborah A, White Janson J, Marvin Colby T, Miller Danny E, Grand Katheryn L, Sanchez-Lara Pedro A, Schweitzer Daniela, Al-Zaidan Hamad I, Al Masseri Zainab, Alkuraya Fowzan S, Lin Angela E
Genetics Unit, MassGeneral Hospital for Children, Massachusetts, USA.
Boston Children's Hospital Medical Biochemical Fellowship, Boston, Massachusetts, USA.
Am J Med Genet A. 2021 Jul;185(7):2136-2149. doi: 10.1002/ajmg.a.62194. Epub 2021 Mar 30.
Van den Ende-Gupta syndrome (VDEGS) is a rare autosomal recessive condition characterized by distinctive facial and skeletal features, and in most affected persons, by biallelic pathogenic variants in SCARF2. We review the type and frequency of the clinical features in 36 reported individuals with features of VDEGS, 15 (42%) of whom had known pathogenic variants in SCARF2, 6 (16%) with negative SCARF2 testing, and 15 (42%) not tested. We also report three new individuals with pathogenic variants in SCARF2 and clinical features of VDEGS. Of the six persons without known pathogenic variants in SCARF2, three remain unsolved despite extensive genetic testing. Three were found to have pathogenic ABL1 variants using whole exome sequencing (WES) or whole genome sequencing (WGS). Their phenotype was consistent with the congenital heart disease and skeletal malformations syndrome (CHDSKM), which has been associated with ABL1 variants. Of the three unsolved cases, two were brothers who underwent WGS and targeted long-range sequencing of both SCARF2 and ABL1, and the third person who underwent WES and RNA sequencing for SCARF2. Because these affected individuals with classical features of VDEGS lacked a detectable pathogenic SCARF2 variant, genetic heterogeneity is likely. Our study shows the importance of performing genetic testing on individuals with the VDEGS "phenotype," either as a targeted gene analysis (SCARF2, ABL1) or WES/WGS. Additionally, individuals with the combination of arachnodactyly and blepharophimosis should undergo echocardiography while awaiting results of molecular testing due to the overlapping physical features of VDEGS and CHDSKM.
范登恩德 - 古普塔综合征(VDEGS)是一种罕见的常染色体隐性疾病,其特征为独特的面部和骨骼特征,且在大多数患者中,存在SCARF2基因的双等位基因致病性变异。我们回顾了36例具有VDEGS特征的已报道个体的临床特征类型和频率,其中15例(42%)已知存在SCARF2基因的致病性变异,6例(16%)SCARF2检测结果为阴性,15例(42%)未进行检测。我们还报告了3例新的具有SCARF2基因致病性变异和VDEGS临床特征的个体。在6例SCARF2基因无已知致病性变异的个体中,尽管进行了广泛的基因检测,仍有3例未得到明确诊断。通过全外显子组测序(WES)或全基因组测序(WGS)发现3例具有致病性ABL1变异。他们的表型与先天性心脏病和骨骼畸形综合征(CHDSKM)一致,该综合征与ABL1变异有关。在这3例未明确诊断的病例中,2例是兄弟,他们接受了WGS以及SCARF2和ABL1的靶向长读长测序,第3例接受了WES和SCARF2的RNA测序。由于这些具有VDEGS典型特征的患者缺乏可检测到的致病性SCARF2变异,因此可能存在基因异质性。我们的研究表明,对具有VDEGS“表型”的个体进行基因检测非常重要,检测方式可以是靶向基因分析(SCARF2、ABL1)或WES/WGS。此外,由于VDEGS和CHDSKM的身体特征有重叠,对于具有蜘蛛指(趾)和睑裂狭小综合征的个体,在等待分子检测结果期间应进行超声心动图检查。